• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: INTEGRA BURLINGTON MA, INC OJEMAN CORTICAL STIMILATOR; NONE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

INTEGRA BURLINGTON MA, INC OJEMAN CORTICAL STIMILATOR; NONE Back to Search Results
Catalog Number OCS2
Device Problems No Audible Prompt/Feedback (2282); Device Operates Differently Than Expected (2913); Noise, Audible (3273)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Type  malfunction  
Event Description
It was reported that the probe did not make any sound while in use.Multiple probes were tried.Add'l info has been requested.
 
Manufacturer Narrative
To date, the device involved in the reported incident has not been received for evaluation.An investigation has been initiated based upon the reported info.
 
Manufacturer Narrative
Integra has completed their internal investigation on (b)(6) 2015.The investigation included: evaluation of actual device review complaint history review of complaints history the complaint incident could not be duplicated or confirmed.The ocs2 ojemann monitor was verified as performing to specification.The dhr was reviewed for ocs2 ojeman cortical stimulator serial number (b)(4).Date of manufacture: (b)(6) 2008.No non-conformance reports were raised during the manufacturing process for this monitor.The dhr review verified all the functionality tests were carried out accordingly and all results of the tests were recorded as within specification prior to the ocs2 been released.Rate of occurrence: during the time period ¿(b)(6)2015¿, the global product usage for ocs2 ojeman cortical stimulator was calculated as 4,427 usages, using the total quantity of ocs stimulator probes to calculate the quantity of usages.The quantity of complaints (1) over the review period with the key word identified in the complaint review can therefore be calculated as 0.02 % (1/4427).Since the complaint incident could not be duplicated and the ocs2 monitor was verified as performing to specification, no root cause can be established for the complaint incident.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
OJEMAN CORTICAL STIMILATOR
Type of Device
NONE
Manufacturer (Section D)
INTEGRA BURLINGTON MA, INC
burlington MA 01803
Manufacturer (Section G)
INTEGRA BURLINGTON, MA, INC.
22 terry avenue
burlington MA 01803
Manufacturer Contact
rowena bunuan
311 enterprise drive
plainsboro, NJ 08536
6099362393
MDR Report Key4824491
MDR Text Key5839619
Report Number1222895-2015-00025
Device Sequence Number1
Product Code GYC
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K924226
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,User Facility,health professional,use
Reporter Occupation Other
Type of Report Initial,Followup
Report Date 05/14/2015
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received06/04/2015
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue NumberOCS2
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer05/21/2015
Is the Reporter a Health Professional? No
Date Manufacturer Received12/01/2015
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured02/01/2008
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Unknown
Patient Sequence Number1
-
-